BioCatalystWatch
VERAWorkspace / VERA / OverviewCompany library
Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

Vera Therapeutics, Inc. (VERA)

Website

Price
Market cap
Next catalystExpected Q4 2026TRUTAKNA (atacicept-vymj) — PIONEER · Phase 2 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Other pipelines

VT-109

BAFF × APRIL

PreINDP1P2P3FilingApproved

Approved / commercial

TRUTAKNA (atacicept-vymj)

BAFF × APRIL

PreINDP1P2P3FilingApproved

History / paused

TRUTAKNA (atacicept-vymj)

BAFF × APRIL

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

VERA PR & News

PR & News

VERA SEC archive